Piramal Healthcare Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Piramal Healthcare Quarterly Results    (NCHP)

Here are the latest quarterly results of Piramal Healthcare. For more details, see the Piramal Healthcare financial fact sheet and Piramal Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Piramal Healthcare Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m25,35928,58429,91129,02531,44134,89136,79735,063 
Other income Rs m7546383651445631,028852669 
Turnover Rs m26,11329,22230,27629,16932,00435,91937,64935,732 
Expenses Rs m12,66014,11016,10313,75814,91114,61817,38014,004 
Gross profit Rs m12,69914,47414,73210,74417,26420,27319,28320,945 
Depreciation Rs m1,2931,1001,1511,2881,2341,3261,3541,582 
Interest Rs m7,2477,4978,3069,09110,16211,68813,15714,085 
Profit before tax Rs m4,9126,5155,6405106,4328,2875,6245,947 
Tax Rs m1,8982,118-33,8001,8101,6282,9302,2432,176 
Profit after tax Rs m3,0154,39739,440-1,3004,8045,3563,3813,771 
Gross profit margin %50.150.649.337.054.958.152.459.7 
Effective tax rate %38.632.5-599.3355.125.335.439.936.6 
Net profit margin %11.915.4131.9-4.515.315.49.210.8 
Diluted EPS Rs 17.5 25.5 228.6 -7.5 27.8 31.0 19.6 21.9  
Diluted EPS (TTM) Rs 72.4 74.5 285.8 264.0 274.3 279.9 70.9 100.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Piramal Healthcare 1QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare PIRAMAL ENTERPRISES With:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Views on news

SUVEN LIFESCIENCES Surges by 5%; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Oct 18, 2019 | Updated on Oct 18, 2019

SUVEN LIFESCIENCES share price has surged by 5% and its current market price is Rs 280. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index are SUVEN LIFESCIENCES (up 5.1%) and PIRAMAL ENTERPRISES (up 6.9%). The top losers are DR. REDDYS LAB and PROCTER & GAMBLE HEALTH (down 0.3%).

PIRAMAL ENTERPRISES Surges by 5%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Oct 18, 2019 | Updated on Oct 18, 2019

PIRAMAL ENTERPRISES share price has surged by 5% and its current market price is Rs 1,546. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index is PIRAMAL ENTERPRISES (up 5.1%). The top losers are PROCTER & GAMBLE HEALTH and DR. REDDYS LAB .

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 18, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS